Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just got my first chance today to see what happened w pps, closed at $1.71, same as yesterday. No change on last day of year, was hoping we would go up today but what a great run over last 30 days- more then doubled share price and now on to 2021.
Titan/Medtronic/ColubrisMX
Trying to determine a BO pps is the wrong way to look at titan. It will all be about the valuation.
https://www.investopedia.com/articles/financial-theory/11/valuing-startup-ventures.asp
So what is the value of Titan? For all of us it will be what we see as value but we aren’t buying so some will say it’s a POS sell all shares, some will say $250M (cost to get to this point), some will say billions (camp I fall into to).
All that matters is the value to Medtronic, JNJ, stryker or any big boy needing to get into robotic surgery to compete w ISRG - who has a MC of $95 Billion. Any of them will need the entire suite of products:
Multi port
Single Port
Endoluminal
They will need patent protection, they will need a next generation platform (not me too, ie TRXC), they will need connectivity, they will need ergonomics.
Multi ports will be a dime a dozen. CMR was recently valued at over $1B, TRXC hit a Valuation of $1B when the JNJ rumors hit. Endoluminal will be a dime a dozen. Auris sold for over $5B. Medrobotics is valued over billion. Olympus, Pentax, Karl Storz will all jump into the mix.
Now Single Port is something special. Titan currently has a market cap of $100+M. Medtronic has asked Titan to help them build their multi port platform. Medtronic has asked Titan to use their IP. Medtronic has asked Titan to utilize their expertise/know how. So what is the value of Titan to Medtronic? What’s the value of Titan to JNJ? Stryker?
Also have to factor in the future of robotic surgery and that it is in its infancy and that in 5-10 years the market oppty will be transforming companies.
I think Titan has a valuation of $5-6B but I’m not a global medical device company with Hundreds of Billions of shareholder value to consider. Intuitive has a $95B market cap and robotic surgery is in it infancy.
You first.
Reach bag! Grab! All together, elephant walk!!!
Titan/Medtronic/ColubrisMX/teleflex.
SPORT19/Titan/Medtronic/Colubris/Teleflex
Per SPORT19 - Cary Vance, Titan BOD, xCath CEO and Chairman of the Board (Colubris sister company)
Per SPORT19 - two very complimentary patents below (one is Titan's [of 150 patents] and one is ColubrisMX [of 1 patent]):
https://uspto.report/patent/app/20200315645
https://pdfaiw.uspto.gov/.aiw?PageNum=0&docid=20200375677&IDKey=07909625C5BC&HomeUrl=http%3A%2F%2Fappft.uspto.gov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%2526Sect2%3DHITOFF%2526p%3D1%2526u%3D%25252Fnetahtml%25252FPTO%25252Fsearch-bool.html%2526r%3D1%2526f%3DG%2526l%3D50%2526co1%3DAND%2526d%3DPG01%2526s1%3D%252522titan%252Bmedical%252522%2526OS%3D%252522titan%252Bmedical%252522%2526RS%3D%252522titan%252Bmedical%252522
Imagine if there was someone who worked directly for Titan, maybe on the board that also had ties to ColubrisMX??
Oh wait, as sport19 alluded to, Titan’s new board of director, Cary Vance, fits the bill. Sport19 was right that it is highly collaborative!
Sport19 found smoking gun in the colubris and Titan patents
Sport19/Titan/Medtronic/colubris/teleflex
Based on Sport19, no way this is going down w these connections he pointed out. Amazing how he pointed that the Titan patent design pictures shows them a perfect match for the ColubrisMX patent design pics
SPORT19/Titan/Medtronic/Colubris/Teleflex
Per SPORT19 - Cary Vance, Titan BOD, xCath CEO and Chairman of the Board (Colubris sister company)
Per SPORT19 - two very complimentary patents below (one is Titan's [of 150 patents] and one is ColubrisMX [of 1 patent]):
https://uspto.report/patent/app/20200315645
https://pdfaiw.uspto.gov/.aiw?PageNum=0&docid=20200375677&IDKey=07909625C5BC&HomeUrl=http%3A%2F%2Fappft.uspto.gov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%2526Sect2%3DHITOFF%2526p%3D1%2526u%3D%25252Fnetahtml%25252FPTO%25252Fsearch-bool.html%2526r%3D1%2526f%3DG%2526l%3D50%2526co1%3DAND%2526d%3DPG01%2526s1%3D%252522titan%252Bmedical%252522%2526OS%3D%252522titan%252Bmedical%252522%2526RS%3D%252522titan%252Bmedical%252522
Patents DON'T INFRINGE, THEY WORK TOGETHER!!!!! SPORT19 has pointed out that out.
SPORT19/Titan/Medtronic/Colubris/Teleflex
FYI, below are the two patent SPORT19 is referring to (make note of the pics as he points out- definite connection):
https://uspto.report/patent/app/20200315645
https://pdfaiw.uspto.gov/.aiw?PageNum=0&docid=20200375677&IDKey=07909625C5BC&HomeUrl=http%3A%2F%2Fappft.uspto.gov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%2526Sect2%3DHITOFF%2526p%3D1%2526u%3D%25252Fnetahtml%25252FPTO%25252Fsearch-bool.html%2526r%3D1%2526f%3DG%2526l%3D50%2526co1%3DAND%2526d%3DPG01%2526s1%3D%252522titan%252Bmedical%252522%2526OS%3D%252522titan%252Bmedical%252522%2526RS%3D%252522titan%252Bmedical%252522
To SPORT19's point about ColurbisMX, here are 2 SEC documents about ColubrisMX and xCath (where Titan's BOD Cary Vance is CEO and Chairman of the Board) -
https://www.sec.gov/Archives/edgar/data/0001694309/000169430917000001/xslFormDX01/primary_doc.xml
https://sec.report/Document/0001694306-17-000001/
To SPORT19's point, it makes sense that Titan and Colubris relationship is "collaborative" in nature. SPORT19/Titan/Medtronic/Colubris/Teleflex
One correction, Colubris is only doing a clinical trial for their endoluminal, per clinical trials data logs link below:
https://clinicaltrials.gov/ct2/show/NCT04651764
they have abandoned their single port platform for now and have solely focused on endoluminal. But as you point out, that makes perfect sense since Medtronic will be incorporating Titan's IP into their Multi-port, will be buying out Titan's Single Port (ENOS - "of one") and then enhancing ColubrisMX's endoluminal (as you pointed out with the patent connection b/t colurbis and Titan) with Titan IP.
Per SPORT19: Medtronic/Titan/Colubris/Teleflex
You tell us, apparently you have unlocked the smoking gun pointing out that that Colubris patent and tying it to the Titan patent, well done. You must know something the rest of us don't. And these guys keep calling you an assclown, shame of them, after all you found the smoking gun that connects it all.
Take a look these two patents (per SPORT19 for pointing it out) - look at the pictures and diagrams - WOW!!!! the pieces fit together like hand and glove - what is crazy is one is the colubris patent and one is the Titan patent - not sure we fill find more definitive proof that Titan and Colubris are working together (aside from the fact pointed out by SPORT19 that Cary Vance is on the Board of directors for Titan)
https://uspto.report/patent/app/20200315645
https://pdfaiw.uspto.gov/.aiw?PageNum=0&docid=20200375677&IDKey=07909625C5BC&HomeUrl=http%3A%2F%2Fappft.uspto.gov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%2526Sect2%3DHITOFF%2526p%3D1%2526u%3D%25252Fnetahtml%25252FPTO%25252Fsearch-bool.html%2526r%3D1%2526f%3DG%2526l%3D50%2526co1%3DAND%2526d%3DPG01%2526s1%3D%252522titan%252Bmedical%252522%2526OS%3D%252522titan%252Bmedical%252522%2526RS%3D%252522titan%252Bmedical%252522
Go look at the patent Sport19 just put out on colubris and look at the patent frankenstin put out - one from
Colubris and one from Titan and they connect together per the pictures. I would definitely say this is the smoking gun that connects Titan, colubris and Medtronic together.
Let’s give a big hand for SPORT19 for finding the colubris patent that connects
To the Titan patent in the Medtronic Enos surgical robotic platform
????????
Great find- looks like colubris has 1 patent- WOW. - colubris patent portfolio of 1! Hold the press.
Breaking news: Per Sport19: colubris and Titan working together!!!
Great post and as you pointed out, one of Titans newly appointed board of directors, Cary Vance is ceo and chairman of XCath, which is a sister company of colubrismx. XCath and colubris both started by Daniel Kim out of U of Texas. Obviously not a conflict of interest so it must be collaborative in nature. As u stated, Titan’s recent patent highlights them making end effectors for an endoluminal platform- so according to you it must be colubris endoluminal.
Per SPORT19 - Medtronic/Titan/colubris
Yes but I have been saying for years that they weren’t going it alone and would be bought out by one of the big boys while I were saying they would go it alone. As I’ve said, what do I care if it isn’t JNJ and it’s Medtronic- certainly no loss of sleep on my end that it’s Medtronic buying out Titan and not jnj.
And considering I was spot on about Titan only being a buyout scenario, I’m fine w that and don’t really care JNJ dropped the ball. Backermore, you can keep coming back for more enlightenment anytime u want.
Please tell us
Go for what?
What do u think?
Interesting read a year later, w all the new info.
https://www.massdevice.com/medtronic-finally-unveils-its-new-robot-assisted-surgery-system/
Who the fook is Gary?
Colubris has almost zero patent protection. Also Colurbis FDA approved clinical trial is for the endoluminal - they have basically shelved SP with all their focus on Endoluminal.
Well if you were Murtha, you would probably end up doing what he ended up doing is go and partner with Titan Medical and ask them to help Medtronic develop and build out their surgical robotic platfrom using IP and know how. ENOS - "of one" platform - multi, single and endoluminal.
Rather than guess at what Murtha is doing why don't you take notice of what Murtha ACTUALLY DID - partner with Titan. I don't see Medtronic utilizing Colubris IP (if there is any) and know how to help them build out their robotic surgery platforms.
No way we are valued less then Auris BO of $5.2B. Titan has a single port platform, is helping Medtronic w their multi port and appears that they are helping on endoluminal. Starting BO is the Auris value and w Cary Vance on the board of directors (w ties to Auris and colubris) he should be well aware of the value that Titan brings. If Medtronic isn’t willing to offer more, well based on that article that was posted today there appears to be many players that are (and w ISRG having a $90+ Billion Market Cap) the value is completely justified when one company’s (Titan Medical inc - TMDI) IP is helping bring them all into one platform (or as the Greeks refer to it as ENOS).
From the Clinical Trial Detailed Description:
The ColubrisMX Endoluminal Surgical (ELS) System has been developed to assist the colorectal surgeon in performing transanal resection of rectal lesions. The ELS System consists of two main components: the Patient Cart and Surgeon Console. This system gains access to the surgical target by means of a flexible overtube (Colubriscope) that is manually inserted through the anus. The ELS System combines the flexibility of endoscopy to navigate the curvature of endoluminal anatomy with conventional two-handed surgical technique. The Colubriscope has two working channels for two different surgical instruments, and one channel for the videoscope (third-party gastroscope). The surgical instruments are robotically assisted with full triangulation and articulation with up to 7 degrees of freedom in order to improve dexterity in confined spaces. The videoscope is robotically assisted, contained within the Colubriscope, and has adjustable zoom and angulation capabilities. Therefore, the orientation of the camera is decoupled from the orientation of the Colubriscope. This approach improves visualization over that of conventional manual flexible endoscopic procedures, where the camera is fixed to the distal tip of the endoscope and limits visualization based on the orientation of the endoscope.
Must be getting close to the end, ColubrisMX performing clinical trials on the ELS right now and schedule to be completed in January 2021 (just over a month away). Medtronic going for CE Mark and IDE application in Q1 2021 - All utilizing Titan IP
https://clinicaltrials.gov/ct2/show/NCT04651764
100% correct that is not the same snake arm device design that McNally was holding up like a guitar in the ENOS rebranding video - in fact, the one he was holding up was rectangular in design (control head) whereas this recent patent shows a cylinder design. Also, notice the bend in the endoluminal design near the cylinder control head whereas the Single port was more rigid near the rectangular control head.
Titan has over 150 patents (and pending) whereas xCath, colubris have almost nothing in regards to patents. We also don't see much with Medtronic patents related to Surgical robotics. As someone has said, the money is in the patents and Titan has them (Hence why the LARGEST MEDICAL DEVICE COMPANY IN THE WORLD - Medtronic has partnered with Titan and wants to utilize their IP and know how).
All ISRG does is robotics surgery and has OVER A $90 BILLION market cap - Imagine the impact robotic surgery platforms (multi port, single port and endoluminal) that Titan is building and their IP is enhancing for Medtronic will do for Medtronic's market cap and value (Tens of Billions, even hundreds of billions in MC valuation)
I found these 2 SEC documents - very interesting connection b/t xCath and Colubris
https://www.sec.gov/Archives/edgar/data/0001694309/000169430917000001/xslFormDX01/primary_doc.xml
https://sec.report/Document/0001694306-17-000001/
To verify McNally's comment on Titan's endoluminal inspiration - refer to post# 120307 and that patent.
I'm not a patent expert or engineering person but sure looks a component for an endoluminal platform. One thing for sure, it is much different then the device Mcnally held up in the ENOS Rebranding video and strummed like a guitar. Sometimes a picture (or images) can be worth Billions....
McNally has referenced natural orifice capabilities, implying endoluminal capabilities.
I see that Cary Vance's profile has been updated on the Titan website as they added he is president and ceo of Xcath.
https://titanmedicalinc.com/board-of-directors/
"the Opportunity to impact Humanity" David McNally and Perry Genova
Anything that impacts humanity is worth BILLIONS and BILLIONS
https://titanmedicalinc.com/enos/
Sure they could and it would have to be disclosed so it hasn’t happened yet. The closest Titan has is that Medtronic took the $18M offering and owns 19% just under 20% threshold.
Well if Medtronic offered $60M, why wouldn't ISRG just offer $70M to keep it away from a major threat to their business and if ISRG offered $70M, why wouldn't Stryker offer $100M b/c their entire business is at risk and if Stryker offer $100M, why wouldn't JNJ come in and offer $150M b/c their VERB Surgical science project isn't getting it down and if JNJ offered..... and on and on b/c Robotic Surgery means BILLIONS AND BILLIONS OF REVENUE and TENS OF BILLIONS UPONS TENS OF BILLIONS IN MARKET CAP for that company. ISRG only does robotic surgery and has a $90B+ market cap just on robotic surgery.
Titan does still outright own the Single Port platform and has rights to all IP. Until something is signed sealed and delivered there is always a chance. All depends on how desperate a company gets and how valuable they see it. An argument could be made that ISRG should offer a fortune just for Titans Single Port. Why? Multiports will be a dime a dozen and ISRG can’t stop that but scoop up Titans Single Port platform and IP and they would pretty much build a big ass moat around their company and leave most other companies seeking single port to start from scratch and anyone following robotics knows how costly and time consuming that is.
If Medtronic offers $3B for Titan, both Jnj and ISRG would be foolish to not offer more, let alone a slew of other companies that will see there surgical business plummet. If Medtronic doesn’t buy it out sooner, it could get into a bidding war - all good for us.
So exactly to big kahuna’s point medtronic will be submitting for CE Mark and IDE Application in Q1 of calendar year 2021. They also asked Titan Medical to help them build this robot by partnering w them. In order to compete w ISRG they will need Multiport, SINGLE PORT and Endoluminal, which is what Geoff Murtha said, they plan to go big. Colubris for the most part is exclusively working on EndoLuminal right now. Titan has all the IP - over 150 game changing patents. Once Medtronic gets CE mark and IDE approval on their Hugo which is built off Titan IP, should make Titans process much quicker and smoother bc both CE regulatory and FDA Regulatory will have insight into Titans technology and have evaluated it before Titan even submits
so Titan's PPS at close of market last 5 days:
$1.34
$1.32
$1.31
$1.31
$1.35
Looks like the bottom has been set. The Shorts had a massive attack at these 5 trading days and didn't budge a bit.
Shorts got crushed.